Blog, News and Events

15 September 2024

Exhibition at the ISSX/JSSX 2024

The 26th North American ISSX and 39th JSSX joint meeting is empowering scientists through education. PhoenixBio is excited to be sponsoring a booth and attending the the 26th North American ISSX and 39th JSSX Meeting. This meeting will convene at the Hilton Hawaiian Village Waikiki Beach Resort September 15th-18th, 2024. Meet with our team at Booth #112 to learn more about PhoenixBio's capabilities and how we can help you deliver and evaluate the human safety of tomorrow’s therapeutics.

Events

11 September 2024

2024 International HBV Meeting

PhoenixBio is attending the International HBV Meeting in person in Chicago, Illinois on September 11th - 15th, 2024. Meet with our team to learn more about PhoenixBio's capabilities and how we can help you advance and deliver tomorrow’s viral hepatitis therapies.

Events

8 September 2024

Exhibition at the EuroTox 2024

The Congress of the European Societies of Toxicology is organizing EuroTox 2024 to focus on this year's theme “Toxicology – A Quest for safe Chemicals and Medicines”. The program features a variety of topics dealing with safety of drugs and environmental chemicals, new and emerging technologies, personalized medicine, human health effects caused by exposure to chemicals as well as safety issues arising from climate changes. PhoenixBio is excited to be sponsoring a booth and attending the EuroTox 2024 in person at the Tivoli Congress Center in Copenhagen, Denmark on September 8th - 11th, 2024. Meet with our team at Booth #8 to learn more about PhoenixBio's capabilities and how we can help you advance and deliver tomorrow’s technologies.

Events

11 June 2024

Exhibition at the MPS World Summit 2024

The Microphysiological systems (MPS) World Summit presents the latest scientific achievements, discuss the advances and challenges, and enable communication between young and newly interested scientists and pioneers of the MPS field. PhoenixBio is excited to be sponsoring a booth and attending the third annual MPS World Summit in person at the Seattle Convention Center Summit in Seattle, Washington on June 11th - 14th, 2024. Meet with our team at Booth #68 to learn more about PhoenixBio's capabilities and how we can help you advance and deliver tomorrow’s technologies.

Events

5 June 2024

Exhibition at the EASL Congress 2024

The European Association for the Study of the Liver (EASL) Congress 2024 presents a diverse scientific programme tailored to various specialties and levels of expertise in hepatology, including: metabolism, alcohol, toxicity; cirrhosis; liver tumors; viral hepatitis; general hepatology; and more! PhoenixBio is excited to be sponsoring a booth and attending the EASL Congress 2024 in person in Milan, Italy on June 5th - 8th, 2024. Meet with our team at Booth #O2 to learn more about PhoenixBio's capabilities and how we can help you advance and deliver tomorrow’s technologies.

Events

2 May 2024

Increasing translational potential with PXB-mice as an alternative to non-human primates

Non-human primates (NHPs) share a wide range of genetic and physiological features in common with humans. Yet, despite their widespread use in preclinical research, NHP models suffer from several limitations that can lead to a lack of translatability in clinical trials.

PXB-mouse, News, Blog

30 April 2024

Exhibition at the American Society of Cell & Gene Therapy 2024 Meeting

The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for researchers in gene and cell therapy. The meeting will cover a range of topics from cutting-edge studies in cell and gene therapy, viral hepatitis, liver toxicity, MASH/MAFLD, and more. PhoenixBio is excited to be sponsoring a booth and attending ASGCT's 27th Annual Meeting in person at the Baltimore Convention Center in Baltimore, MD on May 7th - 11th, 2024. Meet with our team at Booth #1917 to learn more about PhoenixBio's capabilities and how we can help you advance and deliver tomorrow’s therapies.

Events

26 March 2024

Newsweek Feature: Pioneering Drug Development with Human Liver Models

Breaking News: Revolutionizing Pharmaceutical Innovation with Japan’s PhoenixBio In the realm of pharmaceutical innovation, a new dawn arises with Japan's PhoenixBio leading the charge. With a groundbreaking article recently published, PhoenixBio introduces cutting-edge human liver models boasting an astonishing 90% and higher human hepatocyte composition, redefining drug testing worldwide while upholding the highest ethical standards.